Aegis Capital Corp. Acted as Exclusive Placement Agent on a $5.0 Million Private Placement for SciSparc Ltd. (NASDAQ: SPRC)
Aegis Capital Corp. Acted as Exclusive Placement Agent on a $5.0 Million Private Placement for SciSparc Ltd. (NASDAQ: SPRC)
For more information, please visit: NEW YORK, NY / ACCESSWIRE / October 16, 2023 / Aegis Capital Corp. acted as Exclusive Placement Agent on a $5.0 Million Private Placement for SciSparc Ltd. (NASDAQ:SPRC).
紐約州紐約/ACCESSWIRE/2023 年 10 月 16 日/ Aegis Capital Corp. 在Sciparc Ltd.（納斯達克股票代碼：SPRC）500萬美元的私募中擔任獨家配售代理。
About SciSparc Ltd.
關於 sciSparc Ltd.
SciSparc Ltd. is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists. SciSparc's focus is on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. With this focus, the Company is currently engaged in the following drug development programs based on THC and/or non-psychoactive CBD: SCI-110 for the treatment of Tourette Syndrome, for the treatment of Alzheimer's disease and agitation; SCI-160 for the treatment of pain; and SCI-210 for the treatment of ASD and status epilepticus.
Sciparc Ltd. 是一家處於臨床階段的專業製藥公司，由經驗豐富的高級管理人員和科學家團隊領導。SciParc的重點是創建和增強基於大麻素藥物的技術和資產組合。本着這一重點，該公司目前正在開展以下基於四氫大麻酚和/或非精神活性CBD的藥物開發項目：SCI-110 用於治療圖雷特綜合症，用於治療阿爾茨海默氏病和躁動；SCI-160 用於治療疼痛；SCI-210 用於治療自閉症障礙和癲癇持續狀態。
For more information, please visit:
欲了解更多信息，請訪問：
About Aegis Capital Corporation
關於宙斯盾資本公司
Aegis Capital Corporation ("Aegis") has been in the wealth management and investment banking business since 1984. Aegis is dedicated to providing corporate finance, strategic advisory and related services to public and private companies across multiple sectors and regions. Aegis also provides research, sales and trading services to institutional and retail investors. Aegis offers its investment representatives a conflict free service platform and is able to provide a full-range of products and services including investment banking, wealth management, insurance, retirement planning, structured products, private equity, alternatives, equity research, fixed income and special purpose vehicles.
Aegis Capital Corporation（“Aegis”）自1984年以來一直從事財富管理和投資銀行業務。Aegis致力於爲多個領域和地區的上市和私營公司提供企業融資、戰略諮詢和相關服務。Aegis還爲機構和散戶投資者提供研究、銷售和交易服務。Aegis爲其投資代表提供無衝突服務平台，能夠提供全方位的產品和服務，包括投資銀行、財富管理、保險、退休計劃、結構性產品、私募股權、另類股權、股票研究、固定收益和特殊用途工具。
For more information about this offering or Investment Banking Services please email Banking@aegiscap.com or call (212) 813-1010.
有關此產品或投資銀行服務的更多信息，請發送電子郵件至 Banking@aegiscap.com 或者致電 (212) 813-1010。
Brokerage and investment advisory services are offered through Aegis Capital Corporation, a member of FINRA and SIPC. Investment and insurance products offered are not insured by the FDIC or any other federal government agency, are not deposits or other obligations of, or guaranteed by, a bank or any bank affiliate, and are subject to investment risks, including possible loss of the principal amount invested.
經紀和投資諮詢服務由FINRA和SIPC的成員Aegis Capital Corporation提供。所提供的投資和保險產品不由聯邦存款保險公司或任何其他聯邦政府機構提供保險，也不是銀行或任何銀行附屬機構的存款或其他債務，也不是銀行或任何銀行附屬機構的擔保，並且存在投資風險，包括可能損失投資的本金。
SOURCE: Aegis Capital Corp.
來源： 宙斯盾資本公司